Immunotherapy in Head and Neck Cancer: Where Do We Stand?
Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, Fotis Panagopoulos, Eleni Geladari, Ιrene Karampela, Theodora Stratigou, Μaria Dalamaga
Topics & Concepts
MedicineNivolumabImmunotherapyDurvalumabPembrolizumabOncologyHead and neck squamous-cell carcinomaAvelumabAtezolizumabOncolytic virusTremelimumabTumor microenvironmentCetuximabCancerInternal medicineHead and neck cancerIpilimumabImmunologyColorectal cancerCancer Immunotherapy and BiomarkersHead and Neck Cancer StudiesViral-associated cancers and disorders